21 completed, 3 terminated, 1 recruiting, 1 unknown. 26 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 26 | Completed 21, Terminated 3, Recruiting 1, Unknown 1 |
| Phase 2 | 5 | Completed 2, Terminated 2, Unknown 1 |
Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions Ferric Derisomaltose Injection, Ferric Derisomaltose Injection [MonoFer®] - Iron Deficiency Anemia | Phase 1 | Recruiting | Sichuan Huiyu Pharmaceutical Co., Ltd | 88 | 2026-07-23 | 2026-10-13 |
| Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers Ferric maltol capsule, Ferric maltol suspension - Anemia, Iron Deficiency | Phase 1 | Completed | Shield Therapeutics | 32 | 2020-09-28 | 2025-08-24 |
| Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Iron Sucrose - Epithelial Ovarian Cancer, Anemia | Phase 1 / Phase 2 | Terminated | University of Wisconsin, Madison | 9 | 2019-07-29 | 2023-01-05 |
| Probing the Synergistic Effect of Pre-Biotics & Iron Fortificants in Anemic Subjects Prebiotic + Iron Forificant - Iron-deficiency | Phase 1 / Phase 2 | Completed | University of Veterinary and Animal Sciences, Lahore - Pakistan | 75 | 2019-04-06 | 2019-08-22 |
| Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults Na-GST-1, CPG 10104 - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 24 | 2018-02-01 | 2021-01-13 |
| A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia Ferric carboxymaltose - Iron Deficiency Anemia | Phase 1 | Completed | Sandoz | 71 | 2017-11-29 | 2019-05-30 |
| Lactoferrin Versus Total Dose Infusion (TDI) For Treating Iron Deficiency Anemia in Pregnancy: Role of Nursing Oral lactoferrin, TDI of LMW iron dextran - Iron Deficiency Anemia | Phase 1 / Phase 2 | Completed | Woman's Health University Hospital, Egypt | 99 | 2017-11-01 | 2020-10-27 |
| Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency Ferric Maltol - Iron Deficiency, Anaemia in Children, Iron-Deficiency | Phase 1 | Completed | Shield Therapeutics | 37 | 2017-03-14 | 2021-10-06 |
| Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®) Iron Isomaltoside - Anemia, Deficiency Diseases | Phase 1 | Completed | Pharmacosmos A/S | 24 | 2017-01-06 | 2017-12-12 |
| A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients CSJ137, Placebo - Anemia, Iron-Deficiency | Phase 1 | Completed | Novartis Pharmaceuticals | 40 | 2015-09-22 | 2021-10-12 |
| Ferrous Sulphate Supplement (V0355) in Women With Iron Deficiency Anaemia V0355 - Iron Deficiency Anemia | Phase 1 | Terminated | Pierre Fabre Medicament | 29 | 2015-08-01 | 2016-09-28 |
| Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults Na-APR-1 (M74)/Alhydrogel®, Na-GST-1/Alhydrogel®, Hepatitis B vaccine - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 32 | 2014-11-01 | 2017-05-31 |
| Safety and Immunogenicity Study of Na-GST-1 With or Without CpG Na-GST-1/Alhydrogel®, CpG 10104 - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 24 | 2014-10-01 | 2025-07-04 |
| Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia Z-213 - Iron Deficiency Anemia | Phase 1 | Completed | Zeria Pharmaceutical | 24 | 2014-06-01 | 2015-03-20 |
| A Trial to Evaluate the Safety and Tolerability of a Novel Medical Food for Management of Iron Deficiency Anemia Novel Medical Food - Iron Deficiency Anemia | Phase 1 | Completed | Milton S. Hershey Medical Center | 2 | 2014-05-01 | 2017-01-31 |
| Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults Na-APR-1 (M74)/Alhydrogel®, Gluco-Pyranosylphospho-Lipid A Aqueous Formulation - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 40 | 2013-09-01 | 2019-07-31 |
| Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery EPO, Feraheme - Anemia, Cardiovascular Disease | Phase 1 / Phase 2 | Terminated | University of Texas Southwestern Medical Center | 5 | 2013-04-09 | 2020-10-23 |
| Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia Tardyferon 80 mg - Iron Deficiency Anemia | Phase 1 | Completed | Pierre Fabre Medicament | 55 | 2013-01-01 | 2014-04-15 |
| Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant 10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 40 | 2012-05-01 | 2025-01-06 |
| Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults 10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease | Phase 1 | Completed | Baylor College of Medicine | 102 | 2011-11-01 | 2017-05-31 |
Showing 20 of 26. Sign in to see all of them.
Anemia, Iron-Deficiency (26) · Anemia (8) · Ancylostomiasis (6) · Hookworm Infections (6) · Iron Deficiencies (5) · Neglected Diseases (4) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Diseases (1) · Deficiency Diseases (1) · Heart Diseases (1) · Hematologic Diseases (1) · Hypothyroidism (1) · Iron Metabolism Disorders (1) · Kidney Failure, Chronic (1) · Ovarian Neoplasms (1)
Hemic and Lymphatic Diseases (26) · Metabolic Diseases (26) · Nutritional and Metabolic Diseases (26) · Hematologic Diseases (25) · Iron Metabolism Disorders (25) · Iron Deficiencies (21) · Anemia (18) · Helminthiasis (6) · Infections (6) · Nematode Infections (6) · Parasitic Diseases (6) · Secernentea Infections (6) · Strongylida Infections (6) · Disease Attributes (5)
Ferric Oxide, Saccharated (3) · ferric maltol (2) · CPG-oligonucleotide (1) · D-Worm (1) · Dysprosium (1) · Erythropoietin (1) · Ferrosoferric Oxide (1) · GLA-AF adjuvant (1) · Granuflex E (1) · Hepatitis B Vaccines (1) · Lactoferrin (1) · Prebiotics (1) · Sucrose (1) · Thyroxine (1) · Vitamin E (1)
Baylor College of Medicine (6) · Pierre Fabre Medicament (2) · Shield Therapeutics (2) · Duzce University (1) · International Centre for Diarrhoeal Disease Research, Bangladesh (1) · Milton S. Hershey Medical Center (1) · National Heart and Lung Institute (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Novartis Pharmaceuticals (1) · Pharmacosmos A/S (1) · Sandoz (1) · Sichuan Huiyu Pharmaceutical Co., Ltd (1) · University of Colorado, Denver (1) · University of Texas Southwestern Medical Center (1) · University of Veterinary and Animal Sciences, Lahore - Pakistan (1)
United States (12) · United Kingdom (3) · Gabon (2) · Japan (2) · Romania (2) · Brazil (1) · Bulgaria (1) · China (1) · Czechia (1) · Egypt (1) · Israel (1) · Pakistan (1) · Poland (1) · Puerto Rico (1) · Turkey (Türkiye) (1)
David Diemert, MD (3) · Ayola Adegnika, MD (2) · David J Diemert, MD (1) · Dr. Waqas Ahmad, PhD (1) · Hakan Cinemre, Assit. Prof. (1) · Jackie Mitchell, DPhil (1) · Lisa Barroilhet, MD (1) · Morteza Janghorbani, PhD (1) · Nancy F Krebs, MD (1) · Naomi V. Dahl, Pharm.D. (1) · Philip A Poole-Wilson, MD,FRCP (1) · Philip E. Greilich, MD (1) · Shafiqul Alam Sarker, MD, Ph.D. (1) · Warda Helmy, BSN (1)
PMID 28464026, PMID 18191732, PMID 20876669, PMID 27548249, PMID 32926834, PMID 34597297
2015 (1), 2017 (1), R43DK064495 (1)